Bentley Pharmaceuticals, Inc., announced that, following successful review of its Investigational New Drug (IND) application by the FDA, a phase II program is now in effect and under way evaluating Bentley’s human recombinant Intranasal Insulin Spray for the treatment of postprandial hyperglycemia in diabetics.

Naturlose has a beneficial effect on modulating postprandial blood glucose.

End of research on cholesterol medicine torcetrapib is a big blow for firm

Landmark Study compares effectiveness of single therapy with rosiglitazone, sulfonylurea and metformin in a head to head comparison with 4360 newly diagnosed Type 2’s.

Treatment of new-onset type 1 diabetes with peptide is safe and associated with preserved beta-cell function.

Researchers have used cells from human bone marrow to repair damaged pancreatic beta cells in mice. The study offers hopes that these stem cells could be used to treat diabetes in humans. The stem cells also halted damage to the kidneys caused by diabetes.

For patients aged 65 years and older, adverse event rates exceeded 20%, and in-house mortality was 3.2%.

Fish consumption, about one serving per week or more, is associated with reduced cognitive decline, according to the results of a prospective cohort study.

A newly validated definition of metabolic syndrome that uses continuous rather than categorical variables has better predictive power for future diabetes.

People who gamble at least five times a year have more health problems than people who gamble less frequently, a new study reveals. And people with a severe gambling addiction are the most likely to report serious health problems, such as increased heart rate, angina and liver disease when compared …